Morgan Cheatham

Morgan Cheatham is a Vice President at Bessemer Venture Partners, focusing on healthcare and life sciences applications of computation since 2017. Currently involved with multiple organizations, Morgan serves on the NEJM AI Editorial Team and is a Co-Founder of Decoding Bio. Additionally, Morgan holds the position of Board Member at the Coalition for Health AI and is a Limited Partner at Silver Beech Capital Management and First Close Partners. Morgan has significant leadership experience as the Board Director and Interim Chief Executive Officer at FOLX Health. Recognized in Forbes' 30 Under 30 in Venture Capital, Morgan's previous role as an Investment Banking Analyst at Goldman Sachs involved consumer retail and healthcare sectors. Morgan's educational background includes an MD from The Warren Alpert Medical School of Brown University and a Bachelor of Science in Computational Decision Sciences from Brown University.